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C E L L  B I O L O G Y
VPS4 triggers constriction and cleavage of ESCRT-III 
helical filaments
Sourav Maity1, Christophe Caillat2, Nolwenn Miguet2, Guidenn Sulbaran2, Gregory Effantin2, 
Guy Schoehn2, Wouter H. Roos1*, Winfried Weissenhorn2*
Many cellular processes such as endosomal vesicle budding, virus budding, and cytokinesis require extensive 
membrane remodeling by the endosomal sorting complex required for transport III (ESCRT-III). ESCRT-III protein 
family members form spirals with variable diameters in vitro and in vivo inside tubular membrane structures, 
which need to be constricted to proceed to membrane fission. Here, we show, using high-speed atomic force micros-
copy and electron microscopy, that the AAA-type adenosine triphosphatase VPS4 constricts and cleaves ESCRT-III 
CHMP2A-CHMP3 helical filaments in vitro. Constriction starts asymmetrically and progressively decreases the 
diameter of CHMP2A-CHMP3 tubular structure, thereby coiling up the CHMP2A-CHMP3 filaments into dome-like 
end caps. Our results demonstrate that VPS4 actively constricts ESCRT-III filaments and cleaves them before their 
complete disassembly. We propose that the formation of ESCRT-III dome-like end caps by VPS4 within a membrane 
neck structure constricts the membrane to set the stage for membrane fission.
INTRODUCTION
The endosomal sorting complex required for transport (ESCRT) 
machinery catalyzes a wide range of membrane remodeling processes. 
ESCRTs are required for vesicle formation at endosomes, budding 
of some enveloped viruses, cytokinesis, nuclear envelope reforma-
tion, plasma membrane repair, exosome formation, and axon pruning 
(1–8). Common to all processes is the recruitment of ESCRT-III and 
the AAA-type adenosine triphosphatase (ATPase) VPS4 (vacuolar 
protein sorting 4), which have been suggested to constrict membrane 
necks to the point of membrane fission. However, how constriction 
of membrane necks is achieved by ESCRT-III is yet unknown.
Higher eukaryotes express 12 ESCRT-III proteins named CHMP1 
(charged multivesicular body protein 1) to CHMP7 and IST1 (in-
creased sodium tolerance 1 gene product) (3). Yeast ESCRT-III (Vps20, 
Snf7, Vps24, and Vps2) and their human homologs (CHMP6, CHMP4A 
or CHMP4B or CHMP4C, CHMP3 and CHMP2A or CHMP2B) 
are recruited sequentially in the indicated order to the membrane 
(9, 10). Once CHMP4 is recruited, it provides a platform for the 
recruitment of CHMP3 and CHMP2 (11), two ESCRT-III members 
that cap ESCRT-III assembly before recycling (9).
ESCRT-III proteins adopt a closed autoinhibited conformation 
in the cytosol (12–14), and release of autoinhibition (13, 15, 16) leads 
to polymerization into homomeric (17–21) or heteromeric spirals 
in vitro (13, 22–24) and in vivo (18, 25–28). Current understanding 
is that ESCRT-III spirals assemble within membrane neck structures, 
although spirals have yet been only imaged at the cytokinetic mid-
body under physiological conditions (28–30).
An early on-established role for the hexameric VPS4 ATPase in 
the regulation of ESCRT-III polymers is their disassembly, thereby 
recycling ESCRT-III proteins (31). VPS4 uses its “microtubule in-
teracting and trafficking” (MIT) domain to interact with ESCRT-III 
proteins containing a C-terminal “MIT interaction motif” (MIM) 
(32, 33). Upon disassembly, ESCRT-III protein substrate passes via 
the central pore of dynamic VPS4 hexameric assemblies driven by 
adenosine 5′-triphosphate (ATP) hydrolysis (34). Efficient and fast 
VPS4-catalyzed ESCRT-III disassembly in vitro has been confirmed 
on CHMP3 filaments (35) and CHMP2A-CHMP3 polymers (22, 36). 
Recently, the role of VPS4 has been extended to promote the growth 
and turnover of ESCRT-III assemblies in vitro on flat membranes 
(29), consistent with a dynamic recruitment of ESCRT-III to endo-
somal membranes (37). The residence time of ESCRT-III on cellular 
membranes is rather short and complemented by a short transient 
recruitment of several VPS4 complexes required for completion of 
budding and cytokinesis (37–41).
CHMP2A and CHMP3 are engaged late in ESCRT-III assembly, 
recruit VPS4 (31, 42), and block Snf7 (CHMP4) polymerization 
(9, 42). Although only one member of CHMP4 and CHMP2 is es-
sential for HIV-1 release (11), CHMP3 exerts a substantial synergistic 
effect on CHMP2A in HIV-1 budding (43). This is consistent with 
a strong dominant negative effect of truncated CHMP3 on HIV-1 
budding (12), further suggesting an interdependence of CHMP2A 
and CHMP3. In vitro, CHMP2A and CHMP3 form helical tubular 
structures that bind VPS4 on the inside and membrane on the outside 
(22), with average diameters in the range of 47 to 51 nm (43). Few of 
the in vitro assembled CHMP2A-CHMP3 tubes have the filament of 
one tube end coiled up to form a dome-like structure (22). Because 
of the late final engagement of this complex, it has been suggested 
that such a structure could induce membrane neck constriction 
to a few nanometers, which would provide a favorable setting for 
membrane fission (44, 45), although other models have been sug-
gested (46).
However, since it is not clear whether a dome-like end cap struc-
ture can form spontaneously in vivo at all and whether its formation is 
regulated, the central question that remained is how ESCRT-III polymers are 
constricted. Thus, we set out to analyze how CHMP2A-CHMP3 fila-
mentous tubes might be constricted from 50 nm to a few nanometers 
to guide the membrane remodeling process toward membrane fission. 
Our results show that VPS4 actively remodels ESCRT-III CHMP2A- 
CHMP3 filaments, leading to constriction, cleavage, and the gener-
ation of dome- like end caps. We propose that the generation of these 
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structures within a bud neck in vivo primes ESCRT-III for mem-
brane fission.
RESULTS
Effect of VPS4 on CHMP2A-CHMP3 tubular polymers 
observed by high-speed atomic force microscopy
CHMP2A-CHMP3 tubes were assembled as described (22) and bound 
to a lipid bilayer composed of 60% dioleoylphosphatidylcholine 
(DOPC) and 40% dioleoylphosphatidylserine (DOPS). The CHMP2A- 
CHMP3 tubes were then imaged over a period of ~15 min using high- 
speed atomic force microscopy (HS-AFM; Fig. 1A and movie S1) 
(47). The maximal height of these tubes was 50 nm (Fig. 1A), and 
their surface appeared smooth in agreement with previous electron 
microscopy (EM) analysis (43). Next, we tested the effect of VPS4B on 
the tube without ATP. Upon addition of 10 M VPS4B, the tube un-
dergoes very small, local reductions of the tube radius (Fig. 1B and 
movie S2). The line profile in the last panel of Fig. 1B indicates multi-
ple reductions of at least 3 nm in tube radius. No further changes in 
the tube surface topography were observed, not even after an ex-
tended imaging time (fig. S1).
Constriction and disassembly of CHMP2A-CHMP3 tubular 
polymers in the presence of VPS4 and ATP observed  
by HS-AFM
Adding ATP and Mg2+ to the sample led to rapid cleavage (completion 
of constriction) and disassembly of the CHMP2A-CHMP3 tube, as 
could be observed by imaging at 1 frame/s (Fig. 1C). A first cleavage 
occurs at a single position after 13 s, leading to partial tube disassembly 
at 14 s. A second cleavage takes place at approximately 19 s, which is 
followed by other cleavage and disassembly events and completion 
of tube disassembly at 31 s (Fig. 1C and movie S3). This behavior is 
in agreement with the rapid disassembly of CHMP2A-CHMP3 tubes 
revealed by a fluorescent-based assay in vitro (36). Reducing the VPS4B 
concentration to 5 M slows down the process and reveals local con-
striction of the CHMP2A-CHMP3 tubes before cleavage and disas-
sembly. Constriction typically starts asymmetrically, as shown in 
Fig. 2A (movie S4). Figure 2B depicts kymographs along the long axis 
of the tubes (green lines in Fig.  2A), representing the progress of 
constrictions over time. The height profiles at the constriction points 
over time (Fig. 2C) show a reduction of the CHMP2A-CHMP3 tube 
diameter from 45 to <10 nm with an average constriction time of 
87 ± 20 s (fig. S2). Constriction was not due to the forces applied by 
the AFM tip, as control experiments without VPS4B or with VPS4 
without ATP did not lead to constriction (Fig. 1, A and B, fig. S1, and 
movies S1 and S2).
To further corroborate that ATP hydrolysis and the correct 
positioning of the VPS4B MIT domain are required for CHMP2A- 
CHMP3 tube remodeling, we performed experiments with two dif-
ferent VPS4B mutants, which were inactive in a CHMP2A-CHMP3 
tube disassembly assay (36). The catalytic site of the E235Q mutant 
is deficient in ATP hydrolysis, and the I124E mutation affects the 
conformation of the linker that connects the MIT domain to the 
ATPase domains but retains ATPase activity. HS-AFM imaging using 
10 M VPS4B E235Q and ATP revealed local deformations along the 
tube, as observed for VPS4B without ATP. This indicates the proper 
assembly of mutant VPS4B hexamers upon binding to ESCRT-III, 
which, however, does not lead to constriction or cleavage despite the 
presence of ATP (fig. S3 and movie S5). VPS4B I124E plus ATP does 
not even show local tube deformation nor constriction upon incu-
bation of CHMP2A-CHMP3 tubes (fig. S3 and movie S6), suggesting 
that the linker conformation is essential for the functional assem-
bly of VPS4B hexamers on ESCRT-III filaments. This thus corrob-
orates that constriction and cleavage of CHMP2A-CHMP3 tubes by 
VPS4 are ATP dependent and require an optimal positioning of the 
VPS4B hexamer. The latter depends on the linker conformation 
and not only on the MIT domain interaction with ESCRT-III, which 
Fig. 1. Local deformation of VPS4B-treated CHMP2A-CHMP3 tubes and disas-
sembly upon ATP hydrolysis. (A) Clips of HS-AFM images of CHMP2A-CHMP3 tubes 
captured at 0.5 frame/s in the absence of VPS4B, showing no significant change in 
roughness of the tube surface. The inset represents the cross section (axial or radial) 
along the corresponding lines. (B) Clips of HS-AFM images captured at 1 frame/s, 
showing that the 10 M VPS4-treated CHMP2A-CHMP3 tubes undergo discrete re-
ductions of the tube radius (indicated with white arrows) without further struc-
tural changes in the absence of ATP Mg2+. The axial cross section at 231 s shows a 
clear reduction of at least 3 nm in the tube radius. Because of tip convolution, the 
exact value is likely higher than the observed result. (C) Clips of HS-AFM images 
captured at 1 frame/s from 10 M VPS4-treated CHMP2A-CHMP3 tubes in presence 
of 200 M ATP Mg2+. Upon ATP hydrolysis, CHMP2A-CHMP3 tubes disassembled 
within less than 1 min. White arrows show disassembly sites. Average tube height 
is 48 ± 3 nm (n = 30). Scale bars, 100 nm.
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is consistent with the role of the linker region in VPS4 assembly and 
its activity (48).
The kinetics of ESCRT-III CHMP2A-CHMP3 remodeling 
depends on the VPS4 concentration
We next compared the effect of remodeling at decreasing VPS4B 
concentrations. As shown above, 10 M VPS4B induces rapid cleavage 
and almost complete degradation within 20 s (Figs. 1C and 3A and 
movies S3 and S7). The kymograph in Fig. 3B corroborates how 
constriction and disassembly progress over the course of the exper-
iment (see Materials and Methods). At a concentration of 5 M 
VPS4B, cleavage and disassembly occurred significantly later, at time 
scales of hundreds of seconds (Fig. 3, C and D, and movies S4 and 
S8). Under 3 M VPS4B conditions (Fig. 3E and movie S9), remodel-
ing is further slowed down as indicated by a complete constriction 
at ~500 s (see kymograph in Fig. 3F) but without subsequent disas-
sembly. One micromolar VPS4B induces only some minor asymmetric 
constriction after a long incubation (>2000 s) time without comple-
tion of constriction (Fig. 3, G and H, and movie S10). Furthermore, 
we observed that cleavage produces structures resembling dome-like 
end caps or straight ends (fig. S4). The probability of having these 
shapes varies over VPS4B concentration. These results indicate that 
the local concentration of VPS4B is crucial for the assembly of func-
tional hexameric complexes. Achieving the critical concentration for 
hexamer assembly is likely limited by the necessity of VPS4B to 
diffuse into the interior of the tube. Figure 3I quantifies how the 
kinetics of CHMP2A-CHMP3 tube remodeling is dependent on the 
VPS4B concentration and shows that the time required for full con-
striction is significantly reduced at high VPS4B concentrations.
EM analyses of CHMP2A-CHMP3 tube remodeling by VPS4
We next confirmed CHMP2A-CHMP3 tube remodeling by EM 
analyses. Untreated CHMP2A-CHMP3 generally forms straight 
tubes (fig. S5) with variable diameters ranging from 47 to 51 nm 
formed by one-start or multistart helices (43). Consistent with HS-
AFM imaging (Fig. 1B), the presence of VPS4B inside the CHMP2A- 
CHMP3 tube was confirmed by cryo-EM, revealing extra density 
inside the tube in the presence of VPS4 (fig. S6). Furthermore, the 
presence of VPS4 does not induce major morphological changes 
(fig. S6), although small local reductions in diameter can be ob-
served by HS-AFM imaging (Fig. 1B, fig. S1, and movie S2). On the 
basis of the HS-AFM imaging results, we used 5 M VPS4B plus 
ATP and Mg2+ at various incubation times to image remodeling by 
negative-staining EM. This confirmed that constriction often starts 
asymmetrically (Fig. 4A and fig. S7). Complete constriction leads 
to the generation of at least one dome-like end cap (Fig. 4B), a 
structure that was shown to catalyze membrane constriction in silico 
(44). CHMP2A-CHMP3 tube constriction was further confirmed 
by cryo-EM, which revealed early stages of remodeling (Fig. 4C), 
asymmetric cleavage start sites (Fig. 4D), and the generation of dome- 
 like end caps upon tube constriction (Fig. 4E). These results show 
that VPS4 remodels CHMP2A-CHMP3 tubes, constricts them, and 
cleaves them, thereby generating at least one dome-like end cap 
structure.
Fig. 2. In presence of ATP Mg2+, VPS4B mediates local constriction (asymmetric) of the CHMP2A-CHMP3 tubes before disassembly. (A) Clips of HS-AFM images cap-
tured at 0.5 frame/s, showing that the 5 M VPS4B-treated CHMP2A-CHMP3 tubes undergo local constriction before disassembly. The constriction normally appears 
asymmetric (white arrows), i.e., the deformation starts from one side of the tube. Numbers in circles identify three constriction sites in the two tubes. Scale bar, 100 nm. 
(B) Kymographs of both tubes [green lines in (A)]. The progress of the constrictions (numbers in circles) is identifiable from the kymograph. (C) The height profiles of the 
tubes in (A) at nonconstricted site (in black curves) and at the constriction site over time derived from (A) and (B). Each color code is similar to the constriction sites (numbers 
in circles) in (A) and (B).
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DISCUSSION
ESCRT-III has been proposed to assemble inside the membrane 
neck formed at a late stage of a budding vesicle or an enveloped virus. 
The membrane neck needs to be constricted to proceed to mem-
brane fission, thereby splitting the vesicle or virus from the cellular 
membrane (1, 11). In case of HIV-1 budding, it has been shown that 
ESCRT-III proteins are recruited once Gag assembly is completed, 
leading to the transient appearance of ESCRT-III and VPS4 at the 
bud neck (38, 39, 41). Super-resolution imaging revealed an average 
cluster size of 56 ± 12 nm for CHMP2A structures colocalizing with 
HIV-1 buds (40), indicating bud neck diameters of a similar range. 
Upon CHMP4 assembly at the budding site, which might itself already 
induce constriction of the neck, CHMP3 and CHMP2A are recruit-
ed during HIV-1 budding (11, 41). The preferred filament diame-
ter of 47 to 51 nm observed in vitro (43) would thus fit well with the 
range of neck diameters produced upon HIV-1 Gag assembly. Here, 
we show that VPS4 can constrict and cleave CHMP2A-CHMP3 heli-
cal filaments, producing dome-like end cap structures. On the basis 
of these results, we propose a model where CHMP2A-CHMP3 fila-
ments assemble in a bud neck (Fig. 5A) and VPS4 ATP catalysis 
drives constriction from a diameter of ~50 nm to a few nanometers. 
Because CHMP2A-CHMP3 filament formation is likely directional, 
the positioning of the VPS4 hexamer within the tubular structure is 
important, thereby producing either clockwise (Fig. 5B) or anticlockwise 
Fig. 3. Effect of VPS4 concentration on CHMP2A-CHMP3 tube remodeling in presence of ATP Mg2+. (A) Clips of HS-AFM images captured at 1 frame/s, showing a 
rapid disassembly of tube, treated with 10 M VPS4B. (B) Kymograph taken from (A), showing the time and position of first constriction and/or disassembly 
(marked by red arrow). (C) Same as (A) but for 5 M VPS4B-treated tubes. Frame rate, 1 frame/s. (D) Same as (B) but derived from (C). (E and F) Same as (C) and (D), respec-
tively, but for 3 M VPS4B-treated tubes. One can see that, at this concentration, the tube goes through constriction but not disassembly. (G and H) Same as (C) and (D), 
respectively, but for 1 M VPS4B-treated tubes. Images in (G) show that at, 1 M VPS4B concentration (with ATP Mg2+), the tube undergoes a partial constriction after a 
significant amount of time. Frame rate, 0.33 frame/s. (I) Effect of VPS4B concentration on the cleavage of CHMP2A-CHMP3 tubes. The cleavage time is considered 
from the moment of addition of 200 M ATP Mg2+ until the first cleavage occurs (red arrows in the kymograph). For four different concentrations of VPS4B, more than 
20 tubes were investigated. Scale bars, 100 nm.
 o
n







Maity et al., Sci. Adv. 2019; 5 : eaau7198     10 April 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
5 of 9
rotational movements (Fig. 5, B and C) to thread substrate via its 
central pore (34). Correct positioning of VPS4B is further corrobo-
rated by the inactivity of a VPS4B I124E linker mutant that retains 
some ATPase activity but fails to constrict, cleave, and disassemble 
CHMP2A-CHMP3 tubes. The importance of positioning of VPS4B 
on ESCRT-III filaments is consistent with the observation that con-
striction starts asymmetrically and progresses to symmetric constric-
tion (Fig. 5, B and C). In this scenario, the successive decrease of the 
CHMP2A-CHMP3 filament diameter is likely achieved by removal 
of individual CHMP molecules, thereby curling up the filament, 
Fig. 4. EM imaging of CHMP2A-CHMP3 tube remodeling by VPS4B. (A and B) Negative-stain images of CHMP2A-CHMP3 tubes incubated with 5 M VPS4B and 200 M 
ATP Mg2+, indicating (A) start sites of cleavage and (B) the generation of dome-like end caps. Scale bar, 100 nm. (C to E) Cryo-EM images of CHMP2A-CHMP3 tubes incu-
bated with 5 M VPS4B and 200 M ATP Mg2+. (C) Images of early stages of constriction sites, (D) asymmetric constriction start sites, and (E) the generation of dome-
like end caps. Scale bar, 100 nm.
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cleaving it, and generating a dome-like end cap structure (Fig. 5B). 
These structures have been proposed to be able to constrict a mem-
brane tube to 6 nm in silico (44), thereby setting the stage for mem-
brane fission (Fig. 5B). Generation of one dome-like end cap on the 
cytoplasmic side of a budding virus could suffice to induce mem-
brane constriction (Fig. 5B). Alternatively, two VPS4 complexes are 
recruited to the fission site, one acting on the cytoplasmic side and one 
“inside” the virion (Fig. 5C), consistent with the detection of small 
amounts of VPS4 and ESCRT-III proteins inside mature HIV-1 vi-
rions by proteomics analyses (49). Furthermore, super-resolution 
imaging proposed that ESCRT-III complexes might act from within 
a virus bud (50). Because cellular imaging predicts the presence of 
two or more VPS4 complexes at budding sites (37, 39), VPS4 do-
decamer formation, which is dispensable for its enzymatic activity 
(51), might serve to position two side-by-side acting VPS4 complex-
es constricting the membrane from two starting points. We propose 
that this might occur via one VPS4 hexamer rotating and shrinking 
clockwise and another one in an anticlockwise direction during con-
striction (Fig. 5C).
Our in vitro system does not directly yield kinetic parameters on 
constriction, as we cannot determine the exact VPS4B concentration 
at the site of constriction. This is due to the fact that VPS4 needs to 
diffuse into the lumen of the CHMP2A-CHMP3 tubular structure, 
thereby encountering a multitude of low-affinity MIM-binding sites 
(32, 33). Nevertheless, we find that the kinetics of constriction and 
cleavage depends on the VPS4 concentration. Our recorded time scales 
Fig. 5. Model of membrane constriction induced by remodeling of CHMP2A-CHMP3 filaments. (A) CHMP2A-CHMP3 helical filaments assemble within a membrane 
neck structure such as a vesicle or virus bud or at the midbody. Currently, we do not know how many turns assemble in vivo. (B) VPS4 forms an asymmetric hexamer 
structure in the presence of ATP and Mg2+. This structure needs to assemble on functional ESCRT-III filaments, and ATP-driven rotation threads the substrate via its central 
pore. Because CHMP2A-CHMP3 polymer assembly is directional, the assembly of VPS4 acting clockwise or anticlockwise is likely to be important. The assembly of one 
VPS4 complex might be sufficient to induce CHMP2A-CHMP3 constriction, which often starts asymmetrically (middle). This can lead to membrane constriction and cleav-
age of the CHMP2A-CHMP3 filament. (C) Alternatively, two adjacent VPS4B complexes remodel CHMP2A-CHMP3 filaments acting clockwise and anticlockwise, thereby 
leading to the generation of two dome-like end caps and cleavage of the CHMP2A-CHMP3 filament. In both scenarios, constriction of CHMP2A-CHMP3 could prime the 
site for fission, and cleavage of the filament might play an important role in tension release as proposed (53).
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for single- constriction events observed between 100 and 200 s are con-
sistent with the short residence time of VPS4 at HIV-1 budding sites 
(38, 41). The fast constriction kinetics observed at 10 M VPS4 indi-
cates that a high local concentration of VPS4 favors disassembly, 
probably by efficient recycling of VPS4 protomers during the con-
veyor belt–like action of hexameric VPS4 during ESCRT-III protein 
translocation via the central pore (34). Following constriction and 
filament cleavage, CHMP2A-CHMP3 filaments are completely dis-
assembled, consistent with recycling (31) and their disassembly at 
HIV-1 budding sites (41).
Although VPS4 remodeling of ESCRT-III filaments assembled on 
flat membranes has been reported previously, our results provide two 
important observations that distinguish them from the results ob-
tained by Mierzwa et al. (29). First, remodeling on flat ESCRT-III 
polymers starts only from the outer circles, the end of the filament 
(29), while in case of the CHMP2A-CHMP3 tubular structures, fila-
ment constriction can start from within a filament. Second, flat fila-
ments are not cleaved by VPS4 (29), while the CHMP2A-CHMP3 
filaments are efficiently cleaved by VPS4B during the constriction 
process. Cleavage of ESCRT-III has been suggested to induce ten-
sion release required for constriction (52, 53). It is thus possible that 
VPS4 constriction of CHMP2A-CHMP3 filaments generates ten-
sion as well, which is ultimately released by cleavage, thereby con-
tributing to the fission process.
Important open questions concern the nature of the ESCRT-III 
filaments assembled in vivo. First, while CHMP2A-CHMP3 or 
CHMP1B-IST1 tubular helical structures are formed by thin fila-
ments (24, 43), ESCRT-III spirals imaged at the cytokinetic midbody 
are much wider and likely composed of multiple filaments (29, 30). 
However, these spirals have not been detected at vesicle or envel-
oped virus budding sites and may thus be specific for cytokinesis, 
which requires constriction from larger diameters on. Second, it is 
not clear how many ESCRT-III filament turns are present at vesicle 
or enveloped virus budding sites. Recent imaging suggested up to 
50 Vps24 (CHMP3) molecules at endosomal budding sites (37), 
which could form one and a half turn of a CHMP2A-CHMP3 helical 
filament (43). Last, our system to image CHMP2A-CHMP3 filament 
constriction and cleavage in vitro can now be extended to wrap mem-
brane around the tubular structure to determine whether the system 
suffices to cleave membrane tubes.
MATERIALS AND METHODS
Protein expression, purification, and CHMP2A-CHMP3  
tube formation
Full-length CHMP3, CHMP2AC containing residues 9 to 161 fused 
to the maltose-binding protein (MBP) VPS4B, and VPS4B E235Q and 
I124E mutants were expressed and purified as described (12, 22). A 
final purification step includes size exclusion chromatography in 
HBS buffer A [20 mM Hepes (pH 7.6) and 150 mM NaCl] for all 
proteins. For tube formation, 10 M CHMP2AC and 15 M CHMP3 
were mixed and incubated overnight. Tubes were concentrated by 
centrifugation at 15,000 rpm in a Sorvall centrifuge.
Surface preparation for HS-AFM
To reduce the surface interaction to ESCRT tubes, we have used a 
lipid bilayer on top of freshly cleaved mica, as modified from litera-
ture (21, 54, 55). The lipid bilayer was formed by absorption of large 
unilamellar vesicles (LUVs) onto freshly cleaved mica. To prepare 
LUVs, the lipids, DOPC, and DOPS from Avanti, polar lipids were 
used. Sixty percent DOPC and 40% DOPS (mol:mol) containing 
1 mg/ml of total lipids were mixed in 200 l of chloroform in a small 
glass vial. Next, chloroform was evaporated using argon gas while 
slowly rotating the vial to produce a lipid film on the glass wall. Last, 
the film was completely dried in a vacuum desiccator for 30 to 45 min. 
Rehydration of the lipid film was performed with 200 l of buffer B 
[10 mM Hepes (pH 7.4), 100 mM NaCl, and 50 mM sucrose]. The 
mixture was immediately vortexed for 30 s, followed by three cycles 
of freeze-thaw using liquid nitrogen. Small aliquots of LUVs were 
stored at −20°C and used within 1 month after preparation. LUVs 
were thawed at room temperature and diluted to a concentration of 
0.2 mg/ml in the recording buffer C [10 mM Hepes, 10 mM tris-HCl 
(pH 7.5), and 150 mM NaCl] before use. Two microliters of diluted 
LUVs was incubated on a freshly cleaved, 1-mm-diameter mica disc 
attached to a small glass rod (HS-AFM sample stage) (56). After in-
cubation for 5 to 10 min, the surface was cleaned three to five times 
with cleaning buffer D [10 mM tris-HCl (pH 7.5), 100 mM NaCl, 
and 10 mM MgCl2].
HS-AFM experiments
Before immobilization, the ESCRT tubes were treated for 30 min 
with 1 mM tobacco etch virus protease to remove the MBP tag from 
CHMP2AC. After removal of MBP, 2 l of ESCRT tubes was incu-
bated on the previously prepared lipid bilayer for 15 min. After the 
incubation time, the surface was cleaned gently with recording buffer. 
The glass rod was then attached to the piezo head of the HS-AFM 
with a small amount of wax. All HS-AFM data were taken in ampli-
tude modulation mode using a sample scanning HS-AFM [Research 
Institute of Biomolecule Metrology (RIBM), Japan] (47, 56). Short 
cantilevers (USC-F1.2-k0.15, NanoWorld, Switzerland) with spring 
constant of 0.15 N/m, resonance frequency around 0.6 MHz, and a 
quality factor of ∼2 in buffer were used. The cantilever-free ampli-
tude is 3 nm, and the set-point amplitude for the cantilever oscillation 
was set around 2.7 nm. Images were taken at 0.2 to 1 frame/s depending 
on the size of the image. Unless mentioned, all the HS-AFM recordings 
were performed in recording buffer. For all experiments with VPS4B 
and/or ATP Mg2+, the indicated concentrations of VPS4B ranging 
from 1 to 10 M (dissolved in recording buffer) were applied direct-
ly to the sample chamber during continuous imaging. The ESCRT-III 
CHMP2A-CHMP3 tubes were first imaged in recording buffer, and 
then, VPS4B was added at indicated concentrations and incubated 
for 3 to 4 min (to provide sufficient time for diffusion of VPS4B inside 
the tubes) before the addition of ATP Mg2+. Because of the pertur-
bation by the added liquid, sometimes tip-sample interactions were 
briefly affected, but never longer than 30 s. The time mentioned in 
the figure panels represents time starting at the first image, that is, 
within 30 s from the moment of VPS4B/ATP addition.
Data analysis and image processing
All the HS-AFM images were processed primarily with Igor Pro with 
a built-in script from RIBM (Japan) and ImageJ software with addi-
tional home-written plugins. The HS-AFM images/movies were only 
processed minimally through tilt correction, drift correction, and 
brightness correction. The kymographs were obtained from the cross 
section at a fixed position (marked for each image) over the entire 
movie. It represents the height distribution along the line cross sec-
tion as a function of time. For each experimental condition, at least 
four tubes were investigated. For the control experiments with VPS4B 
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E235Q and VPS4B I124E, the number of local deformation sites was 
measured for at least nine tubes. For the VPS4B I124E, we found 
several filaments without any local deformation; therefore, the calcu-
lation of the filament length per deformation for this particular case 
is underestimated, and the real value should be higher. Therefore, it 
does not affect our final conclusion.
Electron microscopy
For negative-staining EM, samples were applied to the clean side 
of carbon on mica (carbon/mica interface) and negatively stained with 
2% sodium silicotungstate (pH 7.0). A grid was placed on top of the 
carbon film covered by the sample, which was subsequently air-
dried. Micrographs were taken with a T12 FEI microscope at 120 kV 
and a magnification of ×30,000. For cryo-EM, vitrified samples were 
prepared according to the method of Dubochet and co-workers (57). 
Sample (3.5 l; CHMP2A-CHMP3 tubes) at 1 mg/ml was applied to 
glow- discharged R2/2 Quantifoil grids (Quantifoil Micro Tools GmbH, 
Germany). The excess liquid was blotted with filter paper for 2 s and 
rapidly plunged into liquid ethane at −175°C using a Vitrobot (20°C, 
100% humidity, and force 1). Specimens were observed with a Polara 
electron microscope at 300 kV. Movies (40 frames of 0.1 s and a dose 
of 1 electron/Å2 per frame) were recorded in an automatic mode on 
a K2 summit direct electron detector using Latitude S (Gatan) at a 
nominal magnification of ×30,000 (1.2 Å per pixel at the image level) 
with defocus values between 1.2 and 3.5 m.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/4/eaau7198/DC1
Fig. S1. Stability of VPS4B-treated CHMP2A-CHMP3 tubular structure over an extended period 
of time.
Fig. S2. Constriction time for 5 M VPS4B-treated CHMP2A-CHMP3 tube in the presence  
of ATP Mg2+.
Fig. S3. Effect of VPS4B E235Q and I124E mutants on CHMP2A-CHMP3 tube remodeling.
Fig. S4. Snapshots of constricted tubes.
Fig. S5. Negative staining EM images of CHMP2A-CHMP3 tubes.
Fig. S6. Cryo-EM images of CHMP2A-CHMP3 tubes incubated with 50 M VPS4B in the 
presence of 50 M adenylyl-imidodiphosphate (AMP-PNP) Mg2+.
Fig. S7. Negative staining images of CHMP2A-CHMP3 tubes incubated with 5 M VPS4B and 
200 M ATP Mg2+, indicating asymmetric and symmetric constriction sites, along with 
dome-like end cap formation at the constriction sites.
Movie S1. CHMP2A-CHMP3 tube immobilized on a membrane bilayer without VPS4B.
Movie S2. CHMP2A-CHMP3 tube immobilized on a membrane bilayer with 10 M VPS4B.
Movie S3. CHMP2A-CHMP3 tubes immobilized on a membrane bilayer, preincubated with  
10 M VPS4B.
Movie S4. CHMP2A-CHMP3 tubes immobilized on a membrane bilayer, preincubated with  
5 M VPS4B.
Movie S5. CHMP2A-CHMP3 tubes immobilized on a membrane bilayer, preincubated with 
10 M VPS4B E235Q mutant and 200 M ATP Mg2+.
Movie S6. CHMP2A-CHMP3 tubes immobilized on a membrane bilayer, preincubated with 
10 M VPS4B I124E and 200 M ATP Mg2+.
Movie S7. CHMP2A-CHMP3 tubes immobilized on a membrane bilayer, preincubated with  
10 M VPS4B.
Movie S8. CHMP2A-CHMP3 tubes immobilized on a membrane bilayer, preincubated with  
5 M VPS4B.
Movie S9. CHMP2A-CHMP3 tubes immobilized on a membrane bilayer, preincubated with  
3 M VPS4B.
Movie S10. CHMP2A-CHMP3 tubes immobilized on membrane bilayer, preincubated with  
1 M VPS4B.
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